Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM
Clinical trial NCT04267601 · UNKNOWN
Trial details
- NCT number
- NCT04267601
- Sponsor
- JW Pharmaceutical
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-07-06
- Primary completion
- 2021-03-30
- Enrollment
- 2448
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.